CHRISTOPHER DONZELL: Open Payments
NPI 1780932137 · LAKE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$674 in 37 payments from 16 companies in 2025. Trend: 2023 $735 · 2024 $661 · 2025 $674
Food & beverage: $674
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $100 |
| AstraZeneca Pharmaceuticals LP | 5 | $92 |
| Novo Nordisk Inc | 4 | $71 |
| GlaxoSmithKline, LLC. | 3 | $62 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $59 |
| Esperion Therapeutics, Inc. | 3 | $51 |
| Amgen Inc. | 2 | $43 |
| PFIZER INC. | 2 | $42 |
| Lilly USA, LLC | 2 | $34 |
| Astellas Pharma US Inc | 1 | $23 |
Products named: AIRSUPRA, UBRELVY, TRELEGY ELLIPTA, CAPLYTA, NEXLETOL, NURTEC ODT, MOUNJARO, Ozempic.
Industry payments across MI — which companies pay providers there.
